Rapamycin extends maximal lifespan in cancer-prone mice.
about
Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cellsFinding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging MoleculesMitochondrial biology and Parkinson's diseaseRapalogs in cancer prevention: anti-aging or anticancer?Pathobiology of aging mice and GEM: background strains and experimental designDisruptive chemicals, senescence and immortalityRapamycin Promotes Mouse 4T1 Tumor Metastasis that Can Be Reversed by a Dendritic Cell-Based VaccineAutophagy and cardiovascular aging: lesson learned from rapamycin.Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intakeQuality control systems in cardiac agingIntermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J MiceRapalogs and mTOR inhibitors as anti-aging therapeuticsRapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restrictionLifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycinMitochondrial dysfunction in cardiac agingStaying young at heart: autophagy and adaptation to cardiac agingHyper-mitogenic drive coexists with mitotic incompetence in senescent cells.Rapamycin extends murine lifespan but has limited effects on aging.Physiological frailty index (PFI): quantitative in-life estimate of individual biological age in miceLatest progress in tyrosine kinase inhibitorsGrowth factors, aging and age-related diseases.From rapalogs to anti-aging formula.The key role of growth hormone-insulin-IGF-1 signaling in aging and cancerWhy human lifespan is rapidly increasing: solving "longevity riddle" with "revealed-slow-aging" hypothesis.Hormesis, cell death and aging.Rapamycin slows aging in miceAutophagy in neurodegenerative disorders: pathogenic roles and therapeutic implicationsBerberine suppresses gero-conversion from cell cycle arrest to senescence.TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.Longevity, aging and rapamycin.Environmental cadmium and breast cancer risk.Rapamycin-induced metabolic defects are reversible in both lean and obese miceAlternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system.Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv micePotential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signalingLifespan modulation in mice and the confounding effects of genetic background.Normalizing a hyperactive mTOR initiates muscle growth during obesityLinking nutrition, maturation and aging: from thrifty genes to the spendthrift phenotypeGerosuppression in confluent cells.Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet
P2860
Q24617423-A480E529-20F0-4D5F-8867-DA44EBB3EDC4Q26747742-37CF0E1F-B43D-4D54-B90D-47D15C87CC46Q26824090-1AA86D70-87EB-4506-93F2-41CDD5C8D69CQ26866151-D7B9DFC0-5AF3-4F5E-89DF-3C10F4F8429CQ27008956-86D4D3D6-4B9D-4F7D-9989-89D1E5B01E47Q27026235-796E5634-4DF4-4ED8-81B6-C18830312875Q27317214-7D91686E-5379-413B-8FF3-BDB28BF7733BQ27692538-7ABDD74E-F6C2-4DB3-BF1F-3764C988707DQ28083422-494F90F9-7557-4818-9713-852DE37F1463Q28084341-36F7E8DC-BE84-4D6D-9AD8-A78DC2E20013Q28275005-C4628C99-363C-4424-9D5C-6ED83BF83635Q28286510-8359C98D-537D-431B-87CD-0BF2F94F43FAQ28304066-BBA90816-7AA1-4473-AA92-A696BEC7EE41Q28307873-30198DA1-964A-4C86-A07D-8F855D6EB840Q28389063-9C273C88-A6E0-472F-8AB9-24762EC79CF6Q28393951-13D0A169-5FCF-474C-AEA2-195411DAD50AQ30533934-53B6E3F3-A482-46AD-9B9D-B5F6BE33FDCCQ30541884-C7F2F7DB-85F0-4B92-A08C-ABED6FCB7EF3Q33563538-76CE9853-A418-478A-AEBD-88CB135E9235Q33576849-FC4502A8-C09A-494E-98C3-2DFBD7209B41Q33756946-51AC09C4-7C60-407C-8E7D-9116C0447D37Q33829205-4F251183-EEEF-4910-BBC8-8F875A27BB2DQ33893799-44BEF40B-29C3-41BD-B8C1-8E6A12B751DFQ33896755-DC5071B8-6CFD-4BC7-A7F2-07851CB3B09AQ34217654-A0DCF9C0-5F19-4333-9521-7D04FC1D3D42Q34275079-4BCA9B3F-F3D1-4C1B-A81D-F8FDD3FD186AQ34311607-9878F132-EFC3-4BE6-BBEA-CB6679A5F068Q34366519-AD8F9C54-BB51-42F3-A16B-7B35E75FFCEBQ34391710-F9991EF1-ED75-42B0-B4F7-13B2E225677AQ34396541-06CCAA6E-A98B-4674-9FA4-4FCD4C122DC7Q34424903-46AA52A0-F6B9-4BCD-8049-F8ECFB1976DFQ34461128-CF67B54A-8AA6-46D7-8395-242E1A3BC9F0Q34497857-E1C54700-A91F-4F8C-B040-F99275760B9FQ34554315-31141304-71B3-43F3-939E-8EEE00D483DAQ34567724-A416470F-C9E1-4443-82E5-C1C01B6957C6Q34642886-3AAA3056-1F71-4FD1-8A0B-D0F509A30AD0Q34852371-4EB33D46-2683-4C42-87D1-A39CC486DC7BQ34852394-5B4A3EC6-EF56-4B6E-8CD4-805055C862BBQ34982499-40141402-B967-46BA-AF76-E6CF3262B381Q35080619-AB725A7D-D9BC-42BA-9758-33D43430D876
P2860
Rapamycin extends maximal lifespan in cancer-prone mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Rapamycin extends maximal lifespan in cancer-prone mice.
@ast
Rapamycin extends maximal lifespan in cancer-prone mice.
@en
type
label
Rapamycin extends maximal lifespan in cancer-prone mice.
@ast
Rapamycin extends maximal lifespan in cancer-prone mice.
@en
prefLabel
Rapamycin extends maximal lifespan in cancer-prone mice.
@ast
Rapamycin extends maximal lifespan in cancer-prone mice.
@en
P2093
P2860
P1476
Rapamycin extends maximal lifespan in cancer-prone mice.
@en
P2093
Anna V Semenchenko
Irina G Popovich
Margarita L Tyndyk
Maria N Yurova
Marina P Antoch
Mark A Zabezhinski
Tatiana S Piskunova
Vladimir N Anisimov
P2860
P304
P356
10.2353/AJPATH.2010.091050
P407
P577
2010-04-02T00:00:00Z